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Magnetic hyperthermia and magnetic resonance imaging (MRI) are two of the most important biomedical applications of 
magnetic nanoparticles (MNPs). However, the design of MNPs with good heating performance for hyperthermia and dual 
T1/T2 contrast for MRI remains a considerable challenge. In this work, ultrasmall superparamagnetic iron oxide 
nanoparticles (USPIONs) are synthesized through a simple one-step methodology. A post-synthetic purification strategy 
has been implemented in order to separate discrete nanoparticles from aggregates and unstable nanoparticles, leading to 
USPIONs that preserve chemical and colloidal stability for extended periods of time. The optimized nanoparticles exhibit 
high saturation magnetization and show good heating efficiency in magnetic hyperthermia experiments. Remarkably, the 
evaluation of the USPIONs as MRI contrast agents revealed that the nanoparticles are also able to provide significant dual 
T1/T2 signal enhancement. These promising results demonstrate that USPIONs are excellent candidates for the 
development of theranostic nanodevices with potential application in both hyperthermia and dual T1/T2 MR imaging.
Introduction  
Magnetic nanoparticles (MNPs) present unique physico-
chemical properties that make them very attractive for 








magnetic resonance imaging (MRI).
4
 In particular, iron oxide 
nanoparticles in the form of magnetite and maghemite are, 
without doubt, the most studied MNPs for clinical applications, 
having been used as MRI contrast agents for decades.
5
 Iron 
oxide nanoparticles are usually classified based on their size. 
Superparamagnetic iron oxide nanoparticles (SPIONs) have a 
colloidal nanoparticle size above 50 nm and are easily 
sequestered by the mononuclear phagocyte system (MPS), 
which makes them ideal to image and diagnose liver 
disorders.
6
 However, their short blood circulation time limits 
their clinical applications and some formulations have been 
removed from the market due to their limited scope.
7
 On the 
other hand, ultrasmall superparamagnetic iron oxide 
nanoparticles (USPIONs) have longer blood half-life due to 
their reduced size (hydrodynamic diameter below 50 nm) and 
a surge of interest has emerged for the development of a new 




MRI contrast agents are able to reduce the relaxation times 
of surrounding water protons under the influence of an 
external magnetic field. Reduction of longitudinal relaxation 
times, T1, results into positive contrast (brighter images, signal 
enhancement), whereas reduction of transverse relaxations 
times, T2, leads to a negative contrast (darker images, signal 
destruction).
8
 Although both processes occur simultaneously, 
conventional contrast agents are classified as T1 or T2 
depending on the relaxation time that experiences a major 
reduction in the presence of the contrast agent.
9
 On the other 
hand, dual-mode contrast agents have the advantage of 
providing good contrast in both T1 and T2-weighted images, 
offering unequivocal detection and facilitating the clinical 
diagnosis of diseases.
10
 In the case of iron oxide nanoparticles, 
their contribution to T1 and T2 relaxation processes can be 
modulated by adjusting the nanoparticle size.
11
 Accordingly, 
SPIONS have been traditionally used as T2 contrast enhancers, 
whereas smaller USPIONs with crystal sizes below 10 nm and 
hydrodynamic diameters under 50 nm,  have shown great 
potential as T1 and dual T1/T2 contrast agents.
12–14
   
Iron oxide nanoparticles are also efficient therapeutic 
agents used in magnetic hyperthermia. Under the influence of 
an alternating magnetic field (AMF), MNPs can transform 
magnetic energy into heat. The localized generation of heat 
has been exploited as a therapy for the treatment of tumors, 
since cancer cells are more sensitive to changes of 
temperature.
15
 Mild hyperthermia (41-46 °C) is used to induce 
apoptosis in cancer cells while preserving healthy tissues. This 
therapy is commonly used in combination with radiation or 
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chemotherapy, which results in a synergistic effect that kills 
cancer cells more efficiently.
16
 
Combining magnetic hyperthermia and dual MRI into a 
single platform would therefore be especially useful for the 
development of new theranostic applications, i.e. the 
combination of therapy and diagnosis. However, this is a 
challenging undertaking because of the inherent physical 
limitations of magnetic nanoparticles. Large iron oxide 
nanoparticles present high magnetic moments, which 
contribute to a better heating efficiency and increased T2-
signal enhancement. In contrast, their high magnetism impairs 
their performance as T1 contrast agents due to the 
perturbation of T1 relaxation processes.
11
  On the other hand, 
T1 relaxation is favoured in small iron oxide nanoparticles but 
their small size promotes energy dissipation through Néel’s 
relaxation, limiting greatly heat production and thus any 
potential application for hyperthermia.
17
 Accordingly, most 
research groups have focused on either increasing the heating 
efficiency and T2 contrast of the nanoparticles or reducing 
their size in order to achieve better T1 contrast. In an attempt 
to obtain versatile nanoparticles for both hyperthermia and 
dual T1/T2 applications, we decided to investigate the 
magnetic response of USPIONs with a balanced distribution of 
nanoparticle sizes. 
In this work, we report the preparation of USPIONs using a 
simple cost-effective synthetic method and evaluate their 
potential use for both hyperthermia and dual MRI applications. 
The size of the final nanoparticles was adjusted through a 
post-synthetic purification strategy, which led to highly-stable 
USPIONs with a balanced distribution of sizes centered around 
10 nm. Magnetic characterization studies revealed that the 
nanoparticles present high saturation magnetization, being 
able to produce temperatures in the range of moderate 
hyperthermia. Interestingly, the nanoparticles also showed 
dual T1/T2 signal enhancement in MRI experiments using 
typical clinical magnetic fields of 1.4 and 3.0 T. 
Materials and methods 
Reagents  
FeCl3·6H2O, FeCl2·4H2O, oleic acid and 
cetyltrimethylammonium bromide (CTAB) were purchased 
from Sigma-Aldrich. Chloroform was purchased from Acros 
Organics. Ammonia (32%) and ethanol were purchased from 
Scharlau. 1000 ppm iron solution in nitric acid (single element 
solution for A.A.S.) was purchased from Fisher Chemical. 
Reactions were conducted using distilled water. 
 
Nanoparticle synthesis 
USPIONs composed of oleate-coated Fe3O4 magnetite 
nanocrystals were obtained by a modified coprecipitation 
method.
18
 The reaction was conducted under argon 
atmosphere with mechanical stirring. In a typical procedure, 
50 ml of distilled water were deoxygenated by bubbling argon 
through the solution. Then, temperature was increased up to 
80 °C followed by the addition of 12 g of FeCl3·6H2O and 4.9 g 
of FeCl2·4H2O. Ammonia 32% (19.53 ml) was added to the 
reaction mixture and iron oxide nanoparticles rapidly formed. 
Oleic acid (2.13 ml) was added after 30 min and the reaction 
was left stirring for another 90 min at 80 °C. The reaction was 
allowed to cool to room temperature and centrifuged at 12108 
g (10 min) in order to precipitate the nanoparticles. Successive 
cycles of washing and centrifugation (12108 g, 10 min) were 
conducted using distilled water (3 cycles) and ethanol (3 
cycles). The resulting black material was dried under vacuum 
overnight. Finally, the nanoparticles were resuspended in 
chloroform and centrifuged at 13400 g (20 min) in order to 




In a typical procedure, 1 ml of oleate-coated USPIONs 
suspended in chloroform (6 mg/ml) was added to a 10 mg/ml 
solution of CTAB in water. Then, both solutions were 
thoroughly mixed with a probe sonicator (450 sonifier, 
Branson Ultrasonics Corporations) giving a homogenous oil-in-
water microemulsion. The mixture was heated at 65 °C with 
continuous stirring until chloroform was completely 




Powder X-ray diffraction (PXRD) measurements were 
conducted using a Bruker AXS D8 Advance diffractometer 
equipped with CuKα radiation and working at 40 kV/40 mA. 
The diffraction pattern of iron oxide nanoparticles was 
recorded in the 2θ range between 25 and 65°. 
TEM analysis was performed on a 100 kV JEOL JEM-1010 
transmission electronic microscope operated with AMT image 
capture engine software. SAED images were obtained using a 
200 kV JEM-2100F transmission electronic microscope. 
Samples were prepared by dropping 10 μl of nanoparticles 
suspended in chloroform onto carbon-coated copper grids, 
which were left at room temperature until chloroform was 
completely evaporated. The size of nanoparticles was 
measured using TEM analysis imaging software. SAED images 
were analyzed using the Digital Micrograph Software (version 
3.7.4). 
Dynamic light scattering (DLS) experiments were 
conducted with a Zetasizer Nano ZS (Malvern Instruments) 
equipped with a laser of 633 nm and collecting the signal at 
173 °. Hydrodynamic size distributions were measured three 
times, from which the average PDI and Z-average values were 
obtained.  
Fourier transform infrared spectroscopy (FTIR) was 
performed between 4000 and 400 cm
-1
 in absorbance mode 
using a Tensor 27 FTIR spectrometer (Bruker).  
Thermogravimetric analysis (TGA) was conducted on a 
TGA/SDTA 851e balance from Mettler Toledo. The analysis was 
performed using a range of temperatures from 25 to 1000 °C 
and applying a heating rate of 10 °C/min under a flow of 
nitrogen. 
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Atomic absorption spectroscopy (AAS) measurements were 
conducted on a Perkin Elmer AAnalyst-100 flame atomic 
absorption spectrometer. Samples were prepared by digesting 
a 10 mg/ml water suspension of magnetic nanoparticles with 
nitric acid (1 M) at 55 °C for 48 h. The standard calibration 
curve was prepared using a 1000 ppm iron solution in nitric 
acid (single element solution for A.A.S.). The final iron 
concentration of each sample was obtained as the average 
value from three independent aliquots, which were digested 
separately. 
Magnetic characterization was conducted on a Quantum 
Design (USA) MPMS-XL magnetometer. 50 μl of nanoparticles 
dispersed in chloroform were placed inside a polycarbonate 
capsule and sealed with vacuum grease. Field dependent 
magnetization was recorded at 250 K under decreasing field 
starting from 5 T, in the field range between -5 T and 5 T. In 
the temperature dependent measurements, the sample was 
first cooled down to 5 K in zero magnetic field (zero field 
cooling, ZFC). Then, a magnetic field of 10 mT was applied and 
the magnetic moment of the sample was measured with 
increasing temperature. After reaching 270 K, the magnetic 
moment was measured with decreasing temperature under 
the presence of a magnetic field of 10 mT (field cooling, FC). 
 
Magnetic hyperthermia 
Calorimetric experiments to determine the heating efficiency 
of the nanoparticles were conducted using a custom-made 
magnetic inductor that generates a stable magnetic field of 
15.92 mT at 200 kHz. The magnetic field was generated inside 
an induction coil composed of a copper pipe, which was 
refrigerated using a bath circulator (Isotemp, R28 from 
Fisherband). The different experiments were performed at 
maximum power. On the centre of the inductor, the maximum 
field was estimated using the Biot-Savart equation: 
𝐵𝑀𝐴𝑋 =
𝑖𝑀𝐴𝑋 ·  µ0 · 𝑁




                                                                 (1) 
where BMAX  represents the maximum field, iMAX the maximum 
current circulating in the inductor, µ0 is the permeability of 
free space, N is the number of loops, l is the length of the 
inductor and r is the radius. The intensity current was 
estimated using the Ohm law, registering the voltage in the 
capacitor. As a result, the estimated maximum field intensity 
generated by the magnetic inductor was 15.92 mT. 
Magnetic induction was applied inside a thermostatic 
chamber, which was kept at 37 °C for hyperthermia 
experiments. Samples were measured on disposable plastic 
cuvettes, which were placed inside an isolating holder at the 
center of the induction coil. Temperature of the samples was 
recorded using a fiber optic temperature sensor. The 
nanoparticles were also characterized using a commercial 
magnetic hyperthermia equipment (DM 100 system from nB 
nanoScale Biomagnetics).  
 
Relaxivity measurements 
Relaxation rates (R) were determined at 1.4 T using a minispec 
mq60 spectrometer from Bruker. Samples from 0 to 125 mM 
Fe were pre-heated at 37 °C and kept at this temperature 
during the experiments. T1 and T2 relaxation times were 
measured using standard saturation recovery and cpmg (Carr-
Purcell-Meiboom-Gill) sequences respectively. The final 
relaxivities were obtained from the slope of the linear fit of the 
inverse of the relaxation times (relaxation rates) against the 
millimolar concentration of Fe. 
MR imaging was performed in a 3.0 T horizontal bore MR 
Solutions Benchtop MRI system equipped with 48 G/cm 
actively shielded gradients. To image the samples, a 56-mm 
diameter quadrature birdcage coil was used in 
transmit/receive mode. Samples (from 0 to 100 mM Fe) were 
placed on a custom printed PLA wellplate (300 μL) which was 
then placed in the center of the scanner. Longitudinal 
relaxation times were measured from T1 maps acquired using 
MPRAGE sequences (TI = 12 values (0.025, 0.05, 0.075, 0.125, 
0.225, 0.425, 0.825, 1.625, 3.225, 6.425, 12.825, 23.525 s), TE = 
5 ms, TR = 24 s, AT = 50 m 40 s), while transversal relaxation 
times were measured from T2 maps acquired through MEMS 
sequences (TE = 10 values (0.015 0.03 0.045 0.06 0.075 0.09 
0.105 0.120.135 0.15 s), TR = 1400 ms, NA = 5 and AT = 32 m 00 
s). T1 and T2 maps were reconstructed using ImageJ software 
(http://imagej.nih.gov/ij). As before, the final relaxivities 
(r1/r2) were calculated from the slope of the linear fit of the 
relaxation rates versus the Fe concentration. 
All MR images of phantoms were acquired with an image 
matrix 256x252, FOV 60x60 mm, 3 slices with a slice thickness 
of 1 mm and 0.5 mm slice gap. Image analysis was performed 
using ImageJ software. 
Results and discussion 
Nanoparticle synthesis and purification 
Regarding the preparation of MNPs, Corot et al.
19
 highlighted 
the importance of simple and reliable synthetic methods to 
obtain high-quality MNPs that do not require complex 
purification steps. In this work, USPIONs were prepared using a 
one-step reaction based on the coprecipitation of iron salts in 
a basic aqueous media under argon atmosphere.
18
 Conducting 
the reaction in water facilitates the scale-up of the reaction 
and offers an economic and green synthetic route to produce 
high-quality nanoparticles for biomedical applications. Oleic 
acid was added to the reaction in order to control the growth 
of crystals and to stabilize the final nanoparticles, preventing 
their aggregation.
20
 This is critical in order to obtain stable 
colloidal suspensions of monodisperse nanoparticles. Finally, 
the obtained nanoparticles were dispersed in chloroform in 
order to prevent their oxidation, giving a stable magnetic 
colloidal fluid or ferrofluid (see Fig. S1). 
 
Nanoparticle characterization 
The mild reaction conditions used in coprecipitation methods 
usually lead to nanoparticles with a broad size distribution, 
which is considered the main limitation of this methodology.
21
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In an attempt to separate discrete nanoparticles from 
aggregates and nanoparticles that were not efficiently coated, 
a post-synthetic purification strategy based on fractional 
precipitation was implemented. By gradually increasing the 
time and speed of centrifugation, stable nanoparticles were 
efficiently separated from aggregates and large nanoparticles. 
 
The size distribution of the nanoparticles during the 
precipitation procedure was monitored using dynamic light 
scattering (DLS). As can be seen in Fig. 1A, the initial ferrofluid 
presented a wide distribution of nanoparticle sizes, which was 
significantly reduced after the precipitation procedure. The 
polydispersity index (PDI), a dimensionless parameter used to 
quantify the size distribution broadness, shifted from 0.25 to 
0.11 and the Z-average diameter of the nanoparticles 
decreased from 57.7 to 25.5 nm. With this simple and 
reproducible strategy, the initial wide distribution of 
nanoparticles was adjusted to a population with an average 
hydrodynamic diameter below 50 nm, the size range assigned 
to USPIONs. 
The size and morphology of the nanoparticles were also 
assessed using transmission electron microscopy (TEM). The 
size obtained by TEM analysis refers only to the nanoparticle 
crystal core, in contrast to the previously obtained 
hydrodynamic diameter, which considers the size of the whole 
nanoparticle (core plus organic coating) and the diffuse 
double-layer of solvent molecules around it. The analysis of 
300 measurements from several TEM micrographs revealed 
that the obtained USPIONs are formed by irregularly shaped 
crystals, with sizes ranging from 4 to 26 nm (Fig. 1B). This size 
corresponds to the measurement of the nanoparticles along 
their major axis, giving an average size of 10.3 ± 3.80 nm. As 
can be seen in Figure 1C, the nanoparticle sizes follow a log-
normal distribution. This type of distribution is characteristic of 
magnetic nanoparticles that have been obtained through a 




X-ray diffraction studies showed that the obtained 
USPIONs are highly crystalline, presenting sharp diffraction 
peaks with 2θ values of 30.21, 35.63, 43.25, 53.68, 57.28 and 
62.89 (Fig. 2A). The values and relative intensities of the peaks 
are in agreement with the Bragg reflections of magnetite 
(JCPDS file no. 19-0629), which were indexed as [2 2 0], [3 1 1], 
[4 0 0], [4 2 2], [5 1 1] and [4 4 0].
23
  
Fourier transform infrared spectroscopy (FTIR) was used to 
study the coating of UPSIONs with oleic acid. Oleic acid 
strongly interacts with the surface of iron oxide nanoparticles 







 As can be seen in Fig. 2B, the symmetric and 
asymmetric stretching vibration of C-H bonds in the 2800-3000 
cm
-1
 region are present in the spectrum of both oleic acid and 
oleate-coated USPIONs but not in the uncoated nanoparticles. 
In the spectrum of pure oleic acid, the characteristic peak of 
the carboxylic C=O stretch can be found around 1700 cm
-1
. 
This band is not present in the case of oleate-coated USPIONs, 
which exhibit two bands at 1516 and 1410 cm
-1
 that were 
assigned to the symmetric and asymmetric stretching of 
carboxylate groups, in agreement with previous studies.
25,26
 
This result confirms that oleic acid is effectively adsorbed on 
the surface of the nanoparticles as a carboxylate. Finally, the 
peak at 540 cm
-1
 was assigned to the Fe-O stretching vibration 
of the magnetite nanoparticles.  
The amount of oleate adsorbed on the surface of the 
nanoparticles was quantified using thermogravimetric analysis 
(TGA). A sample of pure oleic acid was first analysed in order 
to determine the temperature range in which oleic acid burns. 
Complete degradation was observed between 150 and 600 °C, 
with two main losses around 260 and 360 °C (Fig. S2). TGA of 
the oleate-coated SPIONs showed a similar profile, with a 
20.5% weight loss corresponding to the degradation of the 
oleate coating (Fig. 2C). No further transitions were observed 
above 600 °C, which indicates that the obtained iron oxide 




Fig. 1 Size distribution characterization. (A) Intensity-weighted nanoparticle hydrodynamic size distribution before and after the precipitation procedure. Each measurement was 
repeated three times. (B) Overview TEM micrograph of oleate-stabilized USPIONs after separation. (C) Size distribution of oleate-coated USPIONs after separation fitted to a log-
normal distribution. 
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From the TGA analysis, the amount of oleate molecules in 
each nanoparticle was calculated, giving a ligand density of 
1635 oleate molecules/nanoparticle or 4.9 oleate 
molecules/nm
2
 (see SI for calculations). The reported surface 





 which means that nearly 5 molecules could be 
accommodated in a vertical position in 1 nm
2
. This is the ligand 
density obtained for our oleate-coated USPIONs, which 
indicates that the surface of the nanoparticles is completely 
covered by a monolayer of highly-packed oleate molecules. 
Oleate molecules are most likely arranged in a vertical position 
with the carboxylate groups interacting with the surface of the 
nanoparticles and the hydrophobic tails exposed to the 
outside. Accordingly, the oleate-coated USPIONs are highly 
stable in non-polar organic solvents such as chloroform and 
hexane. 
The colloidal stability of the ferrofluid, which was stored in 
the fridge for several months, was evaluated by DLS analysis. 
Measurements were taken at 6 and 8 months after the 
preparation of the magnetic ferrofluid, showing that the size 
distribution had not changed with time (Fig. S3). The absence 
of aggregation in the ferrofluid is an indicator of the good 
coverage and strong interaction of the oleate molecules with 
the surface of the nanoparticles. The chemical integrity of the 
nanoparticles was also investigated 8 months after the 
preparation of the ferrofluid using selected area electron 
diffraction (SAED). The obtained ring diffraction patterns were 
consistent with the crystal structure of magnetite, indicating 
that the nanoparticles had not experienced any significant 
structural modification with time (Fig. S4). All these results 
confirmed that the oleate-coated USPIONs are highly stable 
and can be stored for extended periods of time. 
The hydrophobicity of the oleate-coated SPIONs is not 
compatible with most biomedical applications, thus a water-
phase transfer was conducted in order to obtain nanoparticles 
stable in aqueous solutions. We employed a water-phase 
transfer strategy based on the use of a secondary 
alkylammonium salt surfactant. The hydrophobic tail of the 
surfactant intercalates between the oleic acid molecules 
through hydrophobic Van der Waals interactions, leading to 
the formation of a hybrid bilayer around the magnetic 
nanoparticles as shown in Fig. 3A.
28,29
 In a typical procedure, 
an aqueous solution of cetyltrimethylammonium bromide 
(CTAB) was mixed with the ferrofluid using a probe sonicator. 
The resulting oil-in-water microemulsion was heated at 65 °C 
under continuous stirring in order to evaporate the 
chloroform. In contrast to the oleate-coated nanoparticles, the 
resulting CTAB-stabilized USPIONs are highly stable in water, 
as shown in Fig. 3B. 
 
Magnetic characterization 
Fig. 3 (A) Interaction of CTAB with oleate molecules on the surface of USPIONs and (B) 
USPIONs suspended in a mixture of water-chloroform before and after the water-
phase transfer. 
Fig. 2 Nanoparticle characterization. (A) X-ray diffraction pattern of oleate-coated USPIONs; B) FTIR spectrum of pure oleic acid (a), uncoated USPIONs (b) and oleate-coated 
USPIONs (c); (C) TGA and DGT of oleate-coated USPIONs. 
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It is well known that below a critical nanoparticle size, the 
magnetic moments of all the atoms within the nanoparticle 
tend to align in the same direction, forming a single magnetic 
domain.
30 These single-domain nanoparticles behave like small 
permanent magnets and therefore their magnetic moments 
will interact with each other and with any external magnetic 
field. However, if single-domain nanoparticles are small 
enough, their individual magnetic moments will be 
randomized by thermal energy, leading to a system with no 
net magnetization.
11
 This unique phenomenon is known as 
superparamagnetism.
31
  Thus, in the absence of an external 
magnetic field, the system presents no net magnetization. 
When an external magnetic field is applied, the individual 
magnetic moments of each nanoparticle align with the field 
and the material becomes rapidly magnetized, leading to the 
saturation magnetization of the material (Fig. 4A). After 
removal of the magnetic field, the magnetic moment of the 
nanoparticles return to a random distribution and the material 
is quickly demagnetized, a very attractive property for 
biomedical applications. 
The magnetic properties of the obtained CTAB-stabilized 
USPIONs was thoroughly investigated. For field-dependent 
magnetization experiments, the nanoparticles were dispersed 
in water and kept frozen at 250 K in order to prevent 
nanoparticle agglomeration, which could lead to misleading 
results. The magnetization curves showed a small hysteresis 
together with negligible remanence and coercivity, confirming 
the superparamagnetic behaviour of the obtained 
nanoparticles (Fig. 4B). The nanoparticles presented high 
saturation magnetization (MS=74 emu/g), close to the MS value 
of bulk Fe3O4 (92 emu/g).
32
 This reduced magnetization 
compared to the bulk state is commonly observed in small 
ferrite nanoparticles.
30,33
 being generally attributed to a 
phenomenon known as spin canting. Spin canting was first 
described as a non-uniform distribution of spins, which implies 
that the spins of the atoms within the nanoparticle are not 
completely aligned.
34
 This distortion of spin alignment is 
expected to be more pronounced at the surface of 
nanoparticles, leading to a higher reduction of saturation 
magnetization in smaller nanoparticles (high surface-to-
volume-ratio).
35
 However, internal structural disorder has also 
been suggested as a source of spin canting and cannot be 
excluded.
36
 Additionally, it has been reported that the organic 
coating commonly used to stabilize iron oxide nanoparticles 
could have a significant influence on the magnetic properties 
of the resulting nanoparticles.
37
 Finally, zero-field cooled/field 
cooled (ZFC/FC) magnetization curves revealed that the CTAB-
stabilized USPIONs exhibit a superparamagnetic behaviour 
above 100 K (Fig. 4C). 
 
Magnetic Hyperthermia 
The generation of heat produced by single-domain magnetic 
nanoparticles under the influence of an alternating magnetic 
field (AMF) can be explained by two mechanisms: Néel and 
Brownian relaxation. The first process is related to the 
rearrangement of the spins of the atoms in the nanoparticle, 
which orientate towards the same direction of the external 
magnetic field.
38
 On the other hand, the external magnetic 
field can induce a physical rotation of the nanoparticle itself in 
a process known as Brownian relaxation. Although both 
relaxation processes occur simultaneously, the relative 
contribution of each of them depends on the hydrodynamic 
properties of both the nanoparticles and the medium where 
they are dispersed.
39
 The heat losses produced by these 
relaxation mechanisms can be determined experimentally by 
measuring the temperature change produced by magnetic 
nanoparticles under the effect of an AMF. 
Calorimetric experiments were conducted using a custom-
made magnetic inductor that generates a stable magnetic field 
of 15.92 mT at 200 kHz. The strength and frequency of the 
magnetic field were chosen in order to meet the criteria for 
safe clinical applications, in which the product H·f should be 








 A refrigerated 
copper induction coil was used to prevent the transfer of heat 
from the inductor to the sample, which was placed at the 
center of the coil inside an insulating holder (Fig. S5). The 
sample and coil were placed inside a thermostatic chamber, in 
which the temperature could be adjusted to simulate the body 
temperature and to control the initial temperature of each 
experiment. 
Three samples (denoted as a, b and c) of increasing 
concentrations of nanoparticles (3.8, 5.7 and 7.6 mg/ml 
respectively) were measured in the custom-made magnetic 
inductor. The samples were pre-heated to 37 °C before the 
application of the AMF and the temperature of the liquid 
circulating inside the coil inductor was also set to 37 °C. The 
AMF was applied for 20 min to each sample, recording the 
increase of temperature every 10 seconds. As can be seen in 
Fig. 5, a steady increase of temperature was registered in all 
cases, indicating that the colloid suspensions are stable under 
the experimental conditions applied. The increase of 
temperature was directly proportional to the concentration of 
Fig. 4 (A) Alignment of individual nanoparticle magnetic moments upon the application 
of an external magnetic field; (B) Field-dependent magnetization curves of CTAB-
stabilized USPI-ONs at 250 K and (C) ZFC/FC curves measured at 100 Oe.
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magnetic nanoparticles, reaching temperatures within the mild 
hyperthermia regime. Only the sample with a higher 
concentration of nanoparticles (sample c) reached 
temperatures above 46 °C after 20 minutes of AMF induction. 
It is important to note that the concentration of nanoparticles 
in all the samples is below the common concentration of 
magnetic nanoparticles used for intratumoral injections (10 
mg/ml).
41
 Finally, the change of temperature in a control water 
sample under 20 minutes of induction was below 1 degree, 
which indicates that the increase of temperature is mainly 
produced by the magnetic nanoparticles.  
The specific absorption rate (SAR, in W/g) is the preferred 
parameter used to measure the heating efficiency of magnetic 










                                                                     (2) 
where mf represents the mass of the tested ferrofluid, mNPs 
corresponds to the mass of magnetic nanoparticles and dT/dt 
represents the rate of temperature increase. Cf is the heat 
capacity of the ferrofluid, which can be assumed equal to that 




) when the amount of nanoparticles in 
the colloid is small compared to the amount of fluid.  
 
The heat losses of magnetic nanoparticles increase with 
the frequency (f) and the strength of the magnetic field (H).
43
 
In order to better compare the heating efficiency of magnetic 
nanoparticles in different experimental setups, an additional 




𝐼𝐿𝑃 =  
𝑆𝐴𝑅
𝑓 𝐻2
                                                                                    (3) 
SAR and ILP values of the synthesised nanoparticles were 
determined using equation 2 and 3. The rate of temperature 
increase was obtained from the heating curves at the initial 
time, since the temperature response is not linear in non-
adiabatic systems due to heat losses to the environment.
45
 For 
comparison purposes, the SAR and ILP values are referred to 
the mass of magnetite (Fe3O4) in each sample, which was 
determined using atomic absorption spectroscopy (AAS). 
Calculated SAR and ILP values are presented in Table 1. The 
obtained values for samples a, b and c are very similar 
independently of the concentration of nanoparticles, as 
expected for experiments conducted at the same frequency 
and field strength.
46
 These results also indicate that the 
nanoparticles are highly stable under the effect of an external 
magnetic field, since the appearance of agglomeration would 
have resulted in varying  SAR and ILP values.
17
  
In order to validate the performance of the custom-made 
magnetic inductor, a forth sample (sample d) with a 
concentration of Fe3O4 similar to sample a, was measured in a 
commercial magnetic hyperthermia equipment. The SAR and 
ILP values obtained in the commercial equipment at 15 mT and 
268 kHz are comparable to those obtained in the custom-
made magnetic inductor, validating its applicability for 
hyperthermia experiments. Finally, the heating efficiency of 
sample d was evaluated using the highest field and frequency 
available in the commercial equipment (H= 25.2 mT and f = 
835 kHz). A rapid increase of temperature was registered in 
the sample, which reached 70 °C within 5 minutes of AMF 
induction (Fig. S6). Accordingly, a significantly higher SAR value 
was obtained (323.22 W/g), demonstrating the great heating 
potential of the developed USPIONs at high fields and 
frequencies. 
 
Table 1 Tested samples, experimental conditions applied (H and f) and calculated 
values of SAR and ILP (referred to the mass of magnetite in each sample). 
 
Relaxivity measurements 
MRI contrast agents are able to reduce the longitudinal and 
transverse relaxation times (T1 and T2) of surrounding water 
protons under the influence of an external magnetic field. 
Relaxation rates are defined as the inverse of relaxation times 
(R1,2 = 1/T1,2), thus an effective MRI contrast agent will 
produce an increase of water relaxation rates. However, this 
effect depends on the concentration of contrast agent and an 
additional parameter is needed in order to compare the 
efficiency of different MRI contrast agents. Longitudinal and 
transverse relaxivities, r1 and r2, are defined as the change of 
water relaxation rates normalized to the concentration of 
contrast agent,
47
 in this case the concentration of iron 
expressed in mM: 
Sample a b c d 
[NPs] (mg/ml) 3.8 5.7 7.6 4.5 
[Fe3O4] (mg/ml) 3.04 4.56 6.08 3.55 
H (mT) 15.92 15.92 15.92 15.00 
f (kHz) 200 200 200 268 
SAR (W/g) 17.90 17.45 17.22 18.58 
ILP (nH m2/kg) 0.55 0.54 0.53 0.48 
Fig. 5 Heating curves of samples a, b and c (3.8, 5.7 and 7.6 mg NPs/ml respectively) 
after 20 minutes of AMF induction (H=15.72 mT, f=200 kHz). Water was used as a 
control. 
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                                                                                     (4) 
Contrast agent relaxivities are also affected by the strength 
of the applied magnetic field. Although the use of ultra-high 
field MRI (7.0 T or higher) is slowly becoming a reality for 
clinical applications,
48
 standard clinical MRI scanners still 
operate at low and intermediate field strengths (from 0.5 T to 
3.0 T). T1 and T2 water relaxation times in the presence and 
absence of the CTAB-stabilized USPIONs were measured using 
a 1.4 T relaxometer and a preclinical MRI scan working at 3.0 T. 
Relaxations rates (R1 and R2) were plotted against the 
concentration of Fe, and relaxivities were obtained from the 
slope of the resulting curve as shown in Fig. 6A. The 
longitudinal and transverse relaxivites obtained at 1.4 T and 
3.0 T along with the corresponding r2/r1 ratios are presented 
in Table 2. 
The nanoparticles presented relatively high r2 relaxivity at 
the two working fields tested. The obtained r2 values are 
similar, consistent with the magnetic saturation exhibited by 
the nanoparticles above 1.0 T (see Figure 4B). Impressively, the 
nanoparticles also showed a considerably high r1 relaxivity at 




), whereas a lower value was obtained at 




). The field dependence of longitudinal 
relaxation is complex due to the contribution of different 
mechanisms,
29
 but in the case of iron oxide nanoparticles a 
reduction of r1 relaxivity is usually observed when the 
magnetic field is increased.
49,50
 
Contrast agents are commonly classified based on their 
r2/r1 ratio. A high r2/r1 value indicates a dominant T2 effect 
and dark contrast will be obtained in T2-weighted images. On 
the other hand, materials with a high r1 relaxivity and a 
relatively low r2/r1 (1)  will be efficient T1 contrast 
agents.
51
At low fields, our USPIONs showed an intermediate 
r2/r1 value of 7.7, characteristic of T1/T2 dual contrast 
agents.
51,52
 When the field was increased to 3.0 T, a higher 
r2/r1 value was obtained due to the reduction of r1. However, 
the dual behavior of the nanoparticles was still evident, as 
demonstrated by the images obtained in the preclinical MRI 
scan (Fig. 6B). When fast spin echo (FSE) T2-weighted 
sequences were applied, a negative contrast was observed. 
However, upon the application of T1-weighted sequences, the 
characteristic bright contrast produced by T1 agents was 
detected. 
 
Table 2  Experimental relaxivity values obtained at 1.4 and 3.0 T, together with 
reported relaxivities for the commercial formulations Feraheme® and Combidex®.21 
aValues reported at 1.5T and 37 °C.  
As shown in Table 2, r1 and r2 relaxivity values at 1.4 T are 
higher than those reported for the USPIONs formulation 
Combidex®, currently under clinical development in Europe for 
the detection of limph node metastases,
53
 or the values 
obtained for the FDA-approved supplement Feraheme®. 
Interestingly, relaxivities are also higher than those reported 
for USPIONs synthesized using more complex high-
temperature procedures,
12,54
 and are even comparable to 
those reported for sophisticated hybrid nanodevices that 
combine different types of T1 and T2 contrast materials.
55,56
 A 
balanced distribution of nanoparticle sizes ranging from 4 nm 
to 26 nm, which are log-normally distributed around 10.3 nm, 
might explain the good performance of the obtained USPIONs 
as dual T1/T2 contrast agents. 
Conclusions  
In this work, highly-stable USPIONs were prepared through a 
one-step coprecipitation method. With this simple 
methodology, gram-scale quantities of nanoparticles were 
obtained using mild reaction conditions, in contrast to other 
sophisticated strategies that require the use of organic 
solvents and high reaction temperatures. The obtained 
nanoparticles and are coated with a highly-packed monolayer 
of oleate molecules, which provides increased dispersibility in 
organic solvents and long-term stability. The developed 
USPIONs are superparamagnetic at room temperature and 
show high saturation magnetization close to that of the bulk 





USPIONs 1.4  20.5 157 7.7 
USPIONs 3.0  5.8 166 28.6 
Feraheme® 1.5 15.0a 89a 5.9 
Combidex® 1.5 9.9a 65a 6.6 
Fig. 6 (A) Dependence of longitudinal (R1) and transverse (R2) relaxation rates with the 
concentration of Fe. (B) T1 and T2-weighted images showing the dual behavior of 
CTAB-stabilized USPIONs. Measurements were conducted at 3.0 T.
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material. These two features contribute to their improved 
heating efficiency, which proved successful in generating 
temperatures within the mild hyperthermia regime. The effect 
of the nanoparticles on water relaxation rates was also 
evaluated, showing r1 and r2 relaxivities higher than those 
reported for clinically used MRI contrast agents. Overall, the 
developed USPIONs appear as a versatile system that 
combines both magnetic hyperthermia and dual T1/T2 MRI 
capabilities with great potential for the development of new 
theranostic nanodevices. 
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